Doctor profile · Federal record

Dr. Arash Mostaghimi, MD, MPA, MPH

Dermatology Physician (CMS: Dermatology) · Internal Medicine Physician · Boston, MA

  • NPI 1922275809
  • Accepts Medicare
  • 19 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
221 Longwood Ave
Boston, MA 021155804
(617) 732-5889

Credentials & registration

NPPES · NUCC
NPI registered
May 2008 — 18 yrs on file
Profile last updated
August 14, 2023
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Massachusetts #232075

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1922275809. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
877
Distinct HCPCS
10
Medicare allowed
$53,285
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 266 70 $2
99214 Established patient office or other outpatient visit, 30-39 minutes 200 134 $103
17000 Destruction of precancer skin growth, 1 growth 121 91 $52
99213 Established patient office or other outpatient visit, 20-29 minutes 100 84 $70
17110 Destruction of skin growth, 1-14 growths 50 42 $71
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 33 13 $84
99215 Established patient office or other outpatient visit, 40-54 minutes 30 21 $153
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 29 29 $138
11102 Biopsy of related skin growth, first growth 22 21 $29
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 14 14 $184

In context: peer comparison

Among 69 peers in Boston Dermatology Physician, average services per provider: 115. This provider delivers 7.6× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$91,675
Transactions
64
Manufacturers
6
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 19 $38,562.07
Boehringer Ingelheim International GmbH 24 $30,869.18
Pfizer INC. 7 $10,888.69
Boehringer Ingelheim Pharmaceuticals, INC. 11 $5,884.21
Eli Lilly and Company 2 $5,400.00
Sun Pharmaceutical Industries INC. 1 $70.72

By nature of payment

Consulting Fee
$63,213
Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$23,568
Travel and Lodging
$3,636
Food and Beverage
$1,258

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
350
Patients
62
Total drug cost
$612,812
Drug Type Claims Patients Total cost
Ketoconazole Generic 56 19 $917
Prednisone Generic 48 0 $430
Triamcinolone Acetonide Generic 45 28 $920
Clobetasol Propionate Generic 41 15 $6,135
Fluconazole Generic 23 0 $190
Humira Pen (Adalimumab) Brand 22 0 $245,820
Doxycycline Monohydrate Generic 21 0 $804
Valacyclovir (Valacyclovir Hcl) Brand 18 0 $534
Dupixent Pen (Dupilumab) Brand 15 0 $57,731
Clindamycin Phosphate Generic 13 0 $737

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Arash Mostaghimi's medical specialty?
Dr. Arash Mostaghimi practices Dermatology Physician in Boston, MA.
Where does Dr. Arash Mostaghimi practice?
Dr. Arash Mostaghimi practices at 221 Longwood Ave, Boston, MA 021155804. Office phone: 6177325889.
What is Dr. Arash Mostaghimi's NPI?
Dr. Arash Mostaghimi's National Provider Identifier (NPI) is 1922275809, issued by NPPES.
Does Dr. Arash Mostaghimi accept Medicare assignment?
Yes. Dr. Arash Mostaghimi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Arash Mostaghimi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.